Artificial Intelligence is revolutionizing the pharmaceutical industry, according to a recent research report projecting massive growth.
AI Market Growth in Pharma
The AI in pharmaceutical market is expected to surge from USD 3.24 billion in 2024 to an astounding $65.83 billion by 2033. This represents a remarkable CAGR of 39.74%, indicating the rapid adoption of advanced technologies within the sector. 
AI Technologies Driving Industry Change
Leading companies are embracing key AI technologies such as machine learning, deep learning, and generative AI to streamline drug discovery, optimize clinical trials, and enhance patient care. These tools enable pharmaceutical firms to accelerate research, reduce costs, and deliver better outcomes for patients.
The report highlights industry leaders like Genentech and Bio who are at the forefront of this transformation. As AI continues to merge with pharmaceutical processes, we can expect faster drug development, improved treatment personalization, and increased operational efficiency throughout the industry.
Sources:
Source
